article thumbnail

Understanding Climate and Disability Justice: Mitigating Structural Barriers to the Right to Health

Bill of Health

It explains how conditions, forces, and systems, including poverty, discrimination, underlying health disparities, and governance, not only shape daily life but also vulnerability to climate-induced disasters (Figure 1). Source: Jim Evans via Creative Commons License.) Governments are often falling short of this vision.

article thumbnail

Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection

Bill of Health

By Aparajita Lath Two articles published last month in the BMJ analyze the public investment and financing of mRNA COVID-19 vaccines, highlighting the extensive government funding that has supported the development of mRNA technology from 1985 to 2022. government. government substantially de-risking the vaccine development process.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Drug Enforcement Administration (DEA) Pulls Controlled Substance Licenses from Two Central Florida CVS Pharmacies

The Health Law Firm

The US Drug Enforcement Administration (DEA) revoked the registrations (controlled substance licenses) from two CVS pharmacies in Sanford, Florida, on September 12, 2012, according to a number of sources. This decision is in response to a government crackdown on the distribution of painkillers.

article thumbnail

OIG-LEIE, GSA-SAM, and State Medicaid Exclusion Lists: What’s the Difference?

Provider Trust

The SAM.gov database is formerly known as the Government Services Administration’s (GSA) list of Excluded Parties List System (EPLS). In 2012, GSA announced it was migrating data from the EPLS to a new and more comprehensive system called the System for Award Management (SAM).

article thumbnail

What the Law and Bioethics Tell Us About Synthetic Human Embryos

Bill of Health

There is no specific regulation governing such research in the U.S.; it’s just that the federal government won’t fund the research. This “rejuvenation” of mature cell types was the revolutionary discovery of the Japanese biologist Shinya Yamanaka, which won him a share of the 2012 Nobel Prize in Physiology or Medicine.)

Bioethics 298
article thumbnail

April-July 2022 State Regulatory Developments

New Jersey Healthcare Blog

771(a), the Department of Law and Public Safety, Division of Consumer Affairs, State Board of Pharmacy proposed new rules setting forth the requirements to allow a pharmacy to have licensed pharmacists and registered pharmacy technicians perform limited pharmaceutical functions at a location other than on the premises of a pharmacy.

article thumbnail

How to Increase Your Health Plan’s CMS Star Ratings to Earn More Revenue In 2021

Innovaare Compliance

The Affordable Care Act of 2010 mandates the CMS to make quality bonus payments (QBPs) to Medicare Advantage (MA) organizations that achieve at least four stars in a 5-star quality rating system and, starting in 2012, the CMS incentivizes health plans to improve member experiences by increasing the QBP amount, based on their star rating.